| Financial Year |
March 31 2023 |
| Monetary Funds |
887,724,726.53 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
43,074,839.98 |
| Accounts Receivable |
1,938,169,278.64 |
| Advances to Suppliers |
132,945,824.70 |
| Other Receivables |
66,846,112.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
629,917,351.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
260,520,460.65 |
| Total Current Assets |
4,657,248,388.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,967,198.69 |
| Investment Properties |
1,696,260.68 |
| Fixed Assetes |
755,893,145.62 |
| Under-construction Projects |
1,098,214,865.99 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
105,338,476.80 |
| R&D expenses |
-- |
| Goodwill |
833,412,903.80 |
| Long-Term Deferred and Prepaid Expenses |
15,983,713.56 |
| Deferred Income Tax Assets |
120,937,454.16 |
| Other Non-Current Assets |
103,950,881.01 |
| Sub-Total of Non-Current Assets |
3,503,900,992.35 |
| Total Assets |
8,161,149,380.68 |
| Short-Term Loans |
1,132,952,419.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
259,367,050.03 |
| Accounts Payable |
1,210,505,307.33 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,512,712.61 |
| Taxes Payable |
28,744,645.07 |
| Interest Payable |
8,814,654.14 |
| Dividend Payable |
-- |
| Other payables |
13,402,384.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,811,155.19 |
| Other Current Liabilities |
47,206,854.94 |
| Sub-Total of Current Liabilities |
2,926,656,510.71 |
| Long-term Loans |
158,539,938.14 |
| Bonds Payable |
1,018,704,564.90 |
| Long-Term Accounts Payable |
202,533,982.39 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,815,211.13 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,831,761,893.74 |
| Total Liabilities |
4,758,418,404.46 |
| Paid-In Capital(Or Share Stock) |
450,755,761.00 |
| Capital Surplus |
2,240,366,424.52 |
| Surplus Reserve |
62,242,185.26 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
325,502,987.30 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,402,730,976.22 |
| Owner's Equity（Stockholder's Equity） |
3,402,730,976.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,161,149,380.68 |
